The AIDS Institute hosts Congressional Briefing: An Update on Hepatitis C in the United States


The AIDS Institute invites you to a briefing:

An Update on Hepatitis C in the United States

Tuesday, August 2, 2016

12:00-1:30 pm (G-11 Dirksen Senate Office Building)  OR 3:00-4:30 pm (HVC-200 US Capitol Visitor Center)

View C-SPAN's coverage of our briefing HERE.

You’ve read the headlines, now hear the experts.Opportunities to cure the estimated 3 million people living with hepatitis C in the U.S. now exist. But, patients can only be cured if they have access to curative drugs. Much has happened since the first drug was approved in late 2013. Expert panelists will provide a background on hepatitis C, the benefits of providing treatment without restrictions, and how the Federal government is reacting to state Medicaid programs that have restricted access to curative medications.


Dr. John WardDirector, Division of Viral Hepatitis, CDC - View his presentation here

Dr. Michael Fried, Professor of Medicine at & Director of Hepatology, UNC Chapel Hill - View his presentation here

Dr. John CosterDirector, Division of Pharmacy, Center for Medicaid and CHIP Services, CMS

Mr. Allen Thompson, MedStar Patient Living with Hepatitis C


Mr. Carl SchmidDeputy Executive Director, The AIDS Institute